Hakan Parlakpınar
-
- Circadian rhythm and melatonin 31
- Pharmacology top 0.5%
-
- Cardiac Ischemia and Reperfusion 22
- Chemotherapy-induced organ toxicity mitigation 16
- Nephrology top 2%
- Acute Kidney Injury Research 10
-
- Nitric Oxide and Endothelin Effects 17
-
- Electron Spin Resonance Studies 9
-
- Cardiac electrophysiology and arrhythmias 8
-
- Eicosanoids and Hypertension Pharmacology 8
Hakan Parlakpınar
173 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 147
- Endocrine and Autonomic Systems 464
- Pharmacology 457
- Pathology and Forensic Medicine 849
- Complementary and alternative medicine 340
- Nephrology 227
Countries citing papers authored by Hakan Parlakpınar
This map shows the geographic impact of Hakan Parlakpınar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakan Parlakpınar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakan Parlakpınar more than expected).
Fields of papers citing papers by Hakan Parlakpınar
This network shows the impact of papers produced by Hakan Parlakpınar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakan Parlakpınar. The network helps show where Hakan Parlakpınar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hakan Parlakpınar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 13 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 2 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 16 | |
| 13 | 2021 | 4 | |
| 14 | 2021 | 13 | |
| 15 | 2021 | 16 | |
| 16 | 2021 | 3 | |
| 17 | 2020 | 2 | |
| 18 | 2015 | 20 | |
| 19 | 2014 | 1 | |
| 20 | Animals in Research: Reporting In Vivo Experiments: ARRIVE Guidelines-Review | 2012 | 4 |
About Hakan Parlakpınar
Hakan Parlakpınar is a scholar working on Endocrine and Autonomic Systems, Pathology and Forensic Medicine and Biophysics, having authored 182 papers that have together received 4.0k indexed citations. Recurring topics across this work include Circadian rhythm and melatonin (31 papers), Cardiac Ischemia and Reperfusion (22 papers), Nitric Oxide and Endothelin Effects (17 papers), Chemotherapy-induced organ toxicity mitigation (16 papers), Acute Kidney Injury Research (10 papers), Electron Spin Resonance Studies (9 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Eicosanoids and Hypertension Pharmacology (8 papers). The work is most often cited by research in Endocrine and Autonomic Systems (464 citations), Pharmacology (457 citations) and Pathology and Forensic Medicine (849 citations). Hakan Parlakpınar has collaborated with scholars based in Türkiye, United States and China. Frequent co-authors include Ahmet Acet, Nigar Vardı, Mehmet Günata, Alaadin Polat, Engin Şahna, Mehmet Kaya Özer, Burhan Ateş, Aslı Çetin, Yusuf Türköz and Yılmaz Çiğremiş. Their work appears in journals such as Journal of Pineal Research, Cell Biochemistry and Function, Cardiovascular Toxicology, Molecular and Cellular Biochemistry and Acta Histochemica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.